Quality & Compliance

Vaccine development for COVID-19 may have been rapid, but no one has scrimped on safety.

Mark Jordi, President of Jordi Labs, discusses the latest in extractables and leachables science.

QC must evolve to meet progress in biopharmaceutical manufacturing.

How can we reduce animal testing in quality control procedures?

Drug development needs to move more rapidly, but not at the expense of safety.

Lives and livelihoods depend on accelerating large molecule drug production, so biopharma companies must minimize defects and contamination.

Improving productivity and efficiency with electronic records.

It’s time to address the bottlenecks that lie in quality assurance review and release – and digital systems can help.

How fakers are taking advantage of the pandemic.

Sitting Down With... Stephen Tindal, Director, Science & Technology at Catalent Pharma Solutions, to discuss his career in troubleshooting.